Literature DB >> 24343738

Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability.

Caleb Ho1, Xiaopan Yao, Ligeng Tian, Fang-Yong Li, Nikolai Podoltsev, Mina L Xu.   

Abstract

OBJECTIVES: To evaluate the amount of hemophagocytosis in 64 marrow core biopsy specimens and aspirates from 58 patients with clinical suspicion for secondary hemophagocytic lymphohistiocytosis (HLH) or reported findings of hemophagocytosis.
METHODS: A review of medical records assigned patients to a low-risk (45 patients) or high-risk (13 patients) HLH group, and association with histologic findings was examined using the Fisher exact test.
RESULTS: The amount of hemophagocytosis in aspirate or the core biopsy specimen did not correlate with disease probability (P = .17 and P = .63, respectively). Of the clinical/laboratory criteria assessed, the most significant correlations with HLH were highly elevated ferritin (P = .01), cytopenias (P = .02), and fever (P = .009).
CONCLUSIONS: Our findings indicated that marrow histologic findings alone do not reliably predict the probability of HLH, and an isolated finding of hemophagocytosis, even when present in a high amount, lacks specificity for HLH.

Entities:  

Keywords:  Bone marrow; Hemophagocytic; Hemophagocytosis; Lymphohistiocytosis

Mesh:

Substances:

Year:  2014        PMID: 24343738     DOI: 10.1309/AJCPMD5TJEFOOVBW

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  38 in total

Review 1.  Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

2.  Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.

Authors:  Bella Mehta; Shanthini Kasturi; Julie Teruya-Feldstein; Steven Horwitz; Anne R Bass; Doruk Erkan
Journal:  HSS J       Date:  2018-03-26

Review 3.  A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.

Authors:  Naval Daver; Kenneth McClain; Carl E Allen; Sameer A Parikh; Zaher Otrock; Cristhiam Rojas-Hernandez; Boris Blechacz; Sa Wang; Milen Minkov; Michael B Jordan; Paul La Rosée; Hagop M Kantarjian
Journal:  Cancer       Date:  2017-06-16       Impact factor: 6.860

Review 4.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

Review 5.  Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

Authors:  Courtney Crayne; Randy Q Cron
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 6.  Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Authors:  Lauren A Henderson; Randy Q Cron
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

Review 7.  Advances in biomarkers for paediatric rheumatic diseases.

Authors:  Alessandro Consolaro; Giulia C Varnier; Alberto Martini; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2014-12-16       Impact factor: 20.543

8.  Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis.

Authors:  Zaher K Otrock; Brenda J Grossman; Charles S Eby
Journal:  Int J Hematol       Date:  2018-07-24       Impact factor: 2.490

9.  Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.

Authors:  Himanshu Dandu; Geeta Yadav; Hardeep Singh Malhotra; Saurabh Pandey; Ruovinuo Sachu; Kinjalk Dubey
Journal:  Int J Lab Hematol       Date:  2021-06-04       Impact factor: 3.450

10.  The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Authors:  J M Krei; H J Møller; J B Larsen
Journal:  Clin Exp Immunol       Date:  2020-11-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.